Nuvation Bio (NUVB) Current Leases (2021 - 2026)

Nuvation Bio (NUVB) has reported Current Leases for 6 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Leases fell 2.7% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (down 2.7% YoY), while the FY2025 annual figure was $1.9 million, up 13.05% from the prior year.
• Current Leases declined to $1.8 million in Q1 2026 per NUVB's latest filing, from $1.9 million in the prior quarter.
• Across five years, Current Leases topped out at $2.1 million in Q2 2024 and bottomed at $697000.0 in Q1 2022.
• Historically, Current Leases has averaged $1.6 million across 5 years, with a median of $1.8 million in 2025.
• Annual changes were most pronounced in 2023 — Current Leases soared 78.48% — and 2024, when it fell 15.67%.
• Nuvation Bio's Current Leases stood at $1.2 million in 2022, then soared by 63.52% to $2.0 million in 2023, then retreated by 15.67% to $1.7 million in 2024, then advanced by 13.05% to $1.9 million in 2025, then decreased by 2.23% to $1.8 million in 2026.
• Business Quant data shows NUVB's Current Leases at $1.8 million in Q1 2026, $1.9 million in Q4 2025, and $1.9 million in Q3 2025.